**Core Concept**
The question requires knowledge of chemoprophylaxis for chloroquine-resistant falciparum malaria in pregnant women. Chloroquine-resistant Plasmodium falciparum malaria is a serious concern in endemic areas, and pregnant women are at higher risk of severe disease. The chosen chemoprophylaxis drug must be effective, safe, and suitable for use during pregnancy.

**Why the Correct Answer is Right**
Atovaquone-proguanil is the recommended chemoprophylaxis for chloroquine-resistant falciparum malaria in pregnant women. This combination drug works by inhibiting the mitochondrial electron transport chain in the parasite, ultimately leading to its death. Proguanil acts as a weak antagonist of dihydrofolate reductase, while atovaquone targets cytochrome b in the parasite's mitochondria. This dual-action mechanism makes atovaquone-proguanil highly effective against chloroquine-resistant P. falciparum.

**Why Each Wrong Option is Incorrect**
**Option A:** Chloroquine is not suitable for chemoprophylaxis in areas with chloroquine-resistant P. falciparum, as it is ineffective against this strain. Chloroquine-resistant P. falciparum has developed resistance to the drug due to mutations in the P. falciparum chloroquine resistance transporter gene (PfCRT).

**Option B:** Mefloquine can be used for chemoprophylaxis in areas with chloroquine-resistant P. falciparum, but it is not the preferred choice in pregnant women due to potential teratogenic effects and neurotoxicity.

**Option C:** Doxycycline is contraindicated in pregnancy due to its potential to inhibit bone growth and cause tooth discoloration in the developing fetus.

**Clinical Pearl / High-Yield Fact**
The World Health Organization recommends atovaquone-proguanil as the first-line chemoprophylaxis for chloroquine-resistant falciparum malaria in pregnant women, as it is effective, safe, and well-tolerated during pregnancy.

**Correct Answer:** A. Atovaquone-proguanil